Allon Files Preliminary Shelf Prospectus Allon Therapeutics Inc.

Allon Files Preliminary Shelf Prospectus Allon Therapeutics Inc. has filed an initial short form base shelf prospectus with the securities commissions in each province and territory of Canada . The Company is on track to release top-range data from the medical trial in the next half of December 2012. Related StoriesLiposomal sizing and the Coulter principle: an interview with Professor Melvin E. An interview with Professor Lesley Jones Matthew J. Carlyle, Allon's Chief Financial Officer, said positive data from the trial could position Allon to seek regulatory authorization in the PSP market, estimated to be $700-million.Has been recognized time and again for its industry-leading source chain visibility solutions. In addition to the recent recognition by LogiPharma, Acsis offers been named to the Supply & Demand Chain Executive 100 list for just two consecutive years and Acsis customers have already been awarded the Controlling Automation Progressive Manufacturing 100 Award for 2009 and 2010.. Abbott Named Among the Top 10 Companies for Scientists Abbott was recently named one of the Top 10 10 businesses on The Scientist magazine’s Best Places to Work in Industry list. Abbott was rated No. 6 on the list of Large Companies . This is actually the sixth period that Abbott provides been on the list since The Scientist initial started ranking businesses in 2003. This prestigious list is founded on a detailed survey of scientists at life-science businesses and research institutions worldwide.